Treatment With Dalcetrapib Modifies the Relationship Between High-Density Lipoprotein Cholesterol and C-Reactive Protein

Reynaria Pitts, Elise Gunzburger, Christie M. Ballantyne, Philip J. Barter, David Kallend, Lawrence A. Leiter, Eran Leitersdorf, John J.V. McMurray, Stephen J. Nicholls, Eric J. Niesor, Anders G. Olsson, Prediman K. Shah, Jean Claude Tardif, John Kittelson, Gregory G. Schwartz

Research output: Contribution to journalLetter

4 Citations (Scopus)
LanguageEnglish
Pages2488-2490
Number of pages3
JournalJournal of the American College of Cardiology
Volume68
Issue number22
DOIs
Publication statusPublished - 6 Dec 2016

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Pitts, R., Gunzburger, E., Ballantyne, C. M., Barter, P. J., Kallend, D., Leiter, L. A., ... Schwartz, G. G. (2016). Treatment With Dalcetrapib Modifies the Relationship Between High-Density Lipoprotein Cholesterol and C-Reactive Protein. Journal of the American College of Cardiology, 68(22), 2488-2490. https://doi.org/10.1016/j.jacc.2016.09.932